Diabetes is one of the most
life-threatening diseases in the whole world. According to WHO,
347 million people worldwide have diabetes. The leading organization also
predicts that by 2030, diabetes will be the 7th leading cause of
deaths.
The two types of diabetes vary in some
characteristics but the damage to the body is similar. The term “diabetes
mellitus” describes a metabolic disorder of multiple aetiology characterized by
chronic hyperglycaemia with disturbances of carbohydrate, fat and protein
metabolism resulting from defects in insulin secretion, insulin action, or
both”.
Bentham Science
Publishers is one of the leading journals in the STM industry.
It has journals and eBooks pertaining to topics from science, medicine,
technology and the like. One of the journals is Endocrine, Metabolic & Immune Disorders - Drug
Targets. This journal is devoted
to timely reviews of experimental and clinical studies in the field of
endocrine, metabolic, and immune disorders. Specific emphasis is placed on
humoral and cellular targets for natural, synthetic, and genetically engineered
drugs that enhance or impair endocrine, metabolic, and immune parameters and
functions. Original articles related to Immune Disorders and Drug Targeting are
also considered for publication.
A new
research has proven that a drug used to treat the patients
of the Type 2 diabetes, may lead to increased risk of bladder cancer. Type 2
diabetes (formerly called non-insulin-dependent or adult-onset) results from
the body’s ineffective use of insulin. Type 2 diabetes comprises 90% of people
with diabetes around the world, and is largely the result of excess body weight
and physical inactivity.
This recent research may increase the
rate of death among diabetic patients due to drug induced bladder cancer. The
researchers have conducted a systematic review and meta-analysis to determine
the chances of bladder cancer in adults suffering from type 2 diabetes mellitus
using thiazolidinediones. They suggested that type 2 diabetic patients have 40%
more chances of development of cancer.
This study is very helpful for
physicians who are specialist in diabetes management and treatment. It
would be very healthy for patients if they are not prescribed pioglitazone
rather there are various other Antidiabetic drugs that could be prescribed and
they do not have any carcinogenic effect.
No comments:
Post a Comment